Ret Proto-Oncogene Antikörper

Produktnummer ABIN7645447

Dieses Maus Monoklonal-Antikörper erkennt spezifisch Ret Proto-Oncogene in WB, IHC, ICC und IP. Er zeigt eine Reaktivität gegenüber Maus.

Kurzübersicht für Ret Proto-Oncogene Antikörper (ABIN7645447)

Target: Ret Proto-Oncogene (RET)

Reaktivität: Maus

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser Ret Proto-Oncogene Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)

Klon: C1

Produktdetails anti-Ret Proto-Oncogene Antikörper

Verwendungszweck: Monoclonal Antibody to Ret Proto-Oncogene (RET)

Spezifität: The antibody is a mouse monoclonal antibody raised against RET. It has been selected for its ability to recognize RET in immunohistochemical staining and western blotting.

Aufreinigung: Protein A + Protein G affinity chromatography

Immunogen: RPB293Mu01Recombinant Ret ProtoOncogene (RET)

Anwendungsinformationen

Applikationshinweise: Western blotting: 0.5-3 μg/mL,Immunohistochemistry: 5-30 μg/mL,Immunocytochemistry: 5-30 μg/mL,Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Details zu Ret Proto-Oncogene

Target: Ret Proto-Oncogene (RET)

Andere Bezeichnung: Ret Proto-Oncogene

Hintergrund: CDHR16, CRet, PTC, CDHF12, HSCR1, MEN2A, MEN2B, MTC1, RET-ELE1, RET51, C-Ret, Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Cadherin-Related 16

UniProt: P35546

Pathways: RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation